Verition Fund Management’s CME Group CME Stock Holding History

Verition Fund Management’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.13M	Buy	7,200 +2,900	+67%	+$861K	0.01%	985
2025 Q4	$1.17M	Sell	4,300 -9,600	-69%	-$2.61M	﹤0.01%	2036
2025 Q3	$3.76M	Buy	13,900 +1,200	+9%	+$327K	0.02%	1444
2025 Q2	$3.5M	Buy	12,700 +3,100	+32%	+$843K	0.02%	1466
2025 Q1	$2.55M	Buy	9,600 +4,300	+81%	+$1.06M	0.01%	1400
2024 Q4	$1.23M	Sell	5,300 -10,500	-66%	-$2.41M	﹤0.01%	1914
2024 Q3	$3.49M	Hold	15,800	–	–	0.02%	1074
2024 Q2	$3.11M	Buy	15,800 +3,700	+31%	+$764K	0.02%	1021
2024 Q1	$2.61M	Buy	12,100 +9,200	+317%	+$1.93M	0.02%	1064
2023 Q4	$611K	Buy	2,900 +1,600	+123%	+$341K	﹤0.01%	1413
2023 Q3	$260K	Hold	1,300	–	–	﹤0.01%	1823
2023 Q2	$241K	Hold	1,300	–	–	﹤0.01%	1722
2023 Q1	$249K	Sell	1,300 -2,700	-68%	-$488K	﹤0.01%	1634
2022 Q4	$673K	Hold	4,000	–	–	0.01%	1102
2022 Q3	$709K	Buy	+4,000	New	+$791K	0.01%	1647
2022 Q2	–	Sell	-7,300	Closed	-$1.74M	–	2441
2022 Q1	$1.74M	Buy	7,300 +6,300	+630%	+$1.48M	0.02%	1077
2021 Q4	$228K	Buy	+1,000	New	+$220K	﹤0.01%	2165

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Verition Fund Management's CME Position: Q1 2026 in Review

Verition Fund Management reduced its CME Group (CME) stake by 95% in Q1 2026, selling an estimated $4.7M and leaving 872 shares worth $258K. The position accounts for ﹤0.01% of the portfolio, ranked #1847.

Verition Fund Management first reported a position in CME in Q2 2013 and has held it in 36 quarters since. The position peaked at $25.6M in Q1 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Verition Fund Management held 872 shares of CME Group worth $258K as of Q1 2026.
Verition Fund Management sold 15,824 CME Group shares in Q1 2026, an estimated $4.7M.
CME Group made up ﹤0.01% of Verition Fund Management's portfolio in Q1 2026, its #1847 holding.
Verition Fund Management first reported a position in CME Group in Q2 2013 and has held it in 36 quarters since.
Verition Fund Management's CME Group position peaked at $25.6M in Q1 2025.
1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.